title: Haemophilic synovitis: is rifampicin an alternative?
abstract: Rifampicin synoviorthesis has been empirically used for the treatment of haemophilic synovitis for some time. This paper reports on the experience of three Latin American centers with this treatment and compares it with radioactive synoviorthesis results. Chemical synoviorthesis with rifampicin is best indicated in younger patients (< 15 years) and small joint (ankles and elbows).
authors.affiliation: Instituto de Investigaciones Hematologicas M.R. Castex, Academia Nacional de Medicina, Fundacion Argentina de la Hemofilia, Buenos Aires, Argentina.
authors.forename: H
authors.initials: H
authors.lastname: Caviglia
authors.forename: G
authors.initials: G
authors.lastname: Galatro
authors.forename: C
authors.initials: C
authors.lastname: Duhalde
authors.forename: R
authors.initials: R
authors.lastname: Perez-Bianco
mesh_terms: D006467:Hemophilia A / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D013585:Synovitis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000601:surgery
chemical_list: D019384:Nucleic Acid Synthesis Inhibitors; D012293:Rifampin